<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">        <PMID Version="1">30062102</PMID>        <DateRevised>            <Year>2018</Year>            <Month>08</Month>            <Day>02</Day>        </DateRevised>        <Article PubModel="Electronic-eCollection">            <Journal>                <ISSN IssnType="Print">2374-4677</ISSN>                <JournalIssue CitedMedium="Print">                    <Volume>4</Volume>                    <PubDate>                        <Year>2018</Year>                    </PubDate>                </JournalIssue>                <Title>NPJ breast cancer</Title>                <ISOAbbreviation>NPJ Breast Cancer</ISOAbbreviation>            </Journal>            <ArticleTitle>Elucidating therapeutic molecular targets in premenopausal Asian women with recurrent breast cancers.</ArticleTitle>            <Pagination>                <MedlinePgn>19</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1038/s41523-018-0070-x</ELocationID>            <Abstract>                <AbstractText>Breast cancer is an increasing problem in Asia, with a higher proportion of premenopausal patients who are at higher risk of recurrence. Targeted sequencing was performed on DNA extracted from primary tumor specimens of 63 premenopausal Asian patients who relapsed after initial diagnosis of non-metastatic breast cancer. The most prevalent alterations included: <i>TP53</i> (65%); <i>PIK3CA</i> (32%); <i>GATA3</i> (29%); <i>ERBB2</i> (27%); <i>MYC</i> (25%); <i>KMT2C</i> (21%); <i>MCL1</i> (17%); <i>PRKDC, TPR, BRIP1</i> (14%); <i>MDM4, PCDH15, PRKAR1A, CDKN1B</i> (13%); <i>CCND1, KMT2D, STK11</i>, and <i>MLH1</i> (11%). Sixty of the 63 patients (95%) had at least one genetic alteration in a signaling pathway related to cell cycle or p53 signaling. The presence of <i>MCL1</i> amplification, HIF-1-alpha transcription factor network pathway alterations, and direct p53 effectors pathway alterations were independent predictors of inferior overall survival from initial diagnosis. Comparison with non-Asian premenopausal tumors in The Cancer Genome Atlas (TCGA) revealed a higher prevalence of <i>TP53</i> mutations among HER2-positive cancers, and more frequent <i>TP53, TET2</i>, and <i>CDK12</i> mutations among hormone receptor-positive HER2-negative cancers in our cohort. Given the limited number of non-Asian premenopausal breast cancers that had relapsed in TCGA, we compared the frequency of mutations in our cohort with 43 premenopausal specimens from both TCGA and International Cancer Genome Consortium that had relapsed. There was a trend toward higher prevalence of <i>TP53</i> mutations in our cohort. Certain genomic aberrations may be enriched in tumors of poor-prognosis premenopausal Asian breast cancers. The development of novel therapies targeting these aberrations merit further research.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Yap</LastName>                    <ForeName>Yoon-Sim</ForeName>                    <Initials>YS</Initials>                    <AffiliationInfo>                        <Affiliation>1Division of Medical Oncology, National Cancer Centre, Singapore, Singapore.</Affiliation>                        <Identifier Source="ISNI">0000 0004 0620 9745</Identifier>                        <Identifier Source="GRID">grid.410724.4</Identifier>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>2Faculty of Health Sciences, School of Medicine, University of Adelaide, Adelaide, Australia.</Affiliation>                        <Identifier Source="ISNI">0000 0004 1936 7304</Identifier>                        <Identifier Source="GRID">grid.1010.0</Identifier>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Singh</LastName>                    <ForeName>Angad P</ForeName>                    <Initials>AP</Initials>                    <AffiliationInfo>                        <Affiliation>3Oncology Next-Generation Diagnostics, Novartis Institutes for Biomedical Research, Cambridge, USA.</Affiliation>                        <Identifier Source="ISNI">0000 0004 0439 2056</Identifier>                        <Identifier Source="GRID">grid.418424.f</Identifier>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Lim</LastName>                    <ForeName>John H C</ForeName>                    <Initials>JHC</Initials>                    <AffiliationInfo>                        <Affiliation>4Department of Clinical Trials and Epidemiological Sciences, National Cancer Centre, Singapore, Singapore.</Affiliation>                        <Identifier Source="ISNI">0000 0004 0620 9745</Identifier>                        <Identifier Source="GRID">grid.410724.4</Identifier>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Ahn</LastName>                    <ForeName>Jin-Hee</ForeName>                    <Initials>JH</Initials>                    <AffiliationInfo>                        <Affiliation>5Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.</Affiliation>                        <Identifier Source="ISNI">0000 0004 0533 4667</Identifier>                        <Identifier Source="GRID">grid.267370.7</Identifier>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Jung</LastName>                    <ForeName>Kyung-Hae</ForeName>                    <Initials>KH</Initials>                    <AffiliationInfo>                        <Affiliation>5Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.</Affiliation>                        <Identifier Source="ISNI">0000 0004 0533 4667</Identifier>                        <Identifier Source="GRID">grid.267370.7</Identifier>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Kim</LastName>                    <ForeName>Jeongeun</ForeName>                    <Initials>J</Initials>                    <AffiliationInfo>                        <Affiliation>5Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.</Affiliation>                        <Identifier Source="ISNI">0000 0004 0533 4667</Identifier>                        <Identifier Source="GRID">grid.267370.7</Identifier>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Dent</LastName>                    <ForeName>Rebecca A</ForeName>                    <Initials>RA</Initials>                    <AffiliationInfo>                        <Affiliation>1Division of Medical Oncology, National Cancer Centre, Singapore, Singapore.</Affiliation>                        <Identifier Source="ISNI">0000 0004 0620 9745</Identifier>                        <Identifier Source="GRID">grid.410724.4</Identifier>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Ng</LastName>                    <ForeName>Raymond C H</ForeName>                    <Initials>RCH</Initials>                    <AffiliationInfo>                        <Affiliation>1Division of Medical Oncology, National Cancer Centre, Singapore, Singapore.</Affiliation>                        <Identifier Source="ISNI">0000 0004 0620 9745</Identifier>                        <Identifier Source="GRID">grid.410724.4</Identifier>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Kim</LastName>                    <ForeName>Sung-Bae</ForeName>                    <Initials>SB</Initials>                    <AffiliationInfo>                        <Affiliation>5Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.</Affiliation>                        <Identifier Source="ISNI">0000 0004 0533 4667</Identifier>                        <Identifier Source="GRID">grid.267370.7</Identifier>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Chiang</LastName>                    <ForeName>Derek Y</ForeName>                    <Initials>DY</Initials>                    <AffiliationInfo>                        <Affiliation>3Oncology Next-Generation Diagnostics, Novartis Institutes for Biomedical Research, Cambridge, USA.</Affiliation>                        <Identifier Source="ISNI">0000 0004 0439 2056</Identifier>                        <Identifier Source="GRID">grid.418424.f</Identifier>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>07</Month>                <Day>26</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>United States</Country>            <MedlineTA>NPJ Breast Cancer</MedlineTA>            <NlmUniqueID>101674891</NlmUniqueID>            <ISSNLinking>2374-4677</ISSNLinking>        </MedlineJournalInfo>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Nucleic Acids Res. 2015 Jan;43(Database issue):D805-11</RefSource>                <PMID Version="1">25355519</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Natl Cancer Inst. 2015 Feb 23;107(5):null</RefSource>                <PMID Version="1">25713166</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Biol Med. 2014 Jun;11(2):101-15</RefSource>                <PMID Version="1">25009752</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Med. 2015 Jul;4(7):1016-30</RefSource>                <PMID Version="1">25787708</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Cancer. 2005 Jan 10;113(2):302-6</RefSource>                <PMID Version="1">15386413</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Sci Transl Med. 2017 Aug 2;9(401):null</RefSource>                <PMID Version="1">28768804</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nucleic Acids Res. 2001 Jan 1;29(1):308-11</RefSource>                <PMID Version="1">11125122</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Br J Cancer. 1998 Apr;77(7):1130-6</RefSource>                <PMID Version="1">9569050</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Genome Res. 2010 Sep;20(9):1297-303</RefSource>                <PMID Version="1">20644199</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Cancer. 2012 Jun 1;130(11):2629-37</RefSource>                <PMID Version="1">21702035</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2016 Jan 1;34(1):91-101</RefSource>                <PMID Version="1">26578615</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Cancer Res. 2017 Mar;15(3):259-268</RefSource>                <PMID Version="1">28039357</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cell Discov. 2016 Aug 30;2:16025</RefSource>                <PMID Version="1">27625789</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nucleic Acids Res. 2017 Jun 20;45(11):6698-6716</RefSource>                <PMID Version="1">28334900</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nature. 2011 Mar 3;471(7336):110-4</RefSource>                <PMID Version="1">21368834</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncotarget. 2017 Apr 25;8(17):27997-28007</RefSource>                <PMID Version="1">28427202</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nature. 2016 Oct 27;538(7626):477-482</RefSource>                <PMID Version="1">27760111</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Genet. 2011 May;43(5):491-8</RefSource>                <PMID Version="1">21478889</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2016 Sep 20;34(27):3308-14</RefSource>                <PMID Version="1">27480155</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nature. 2012 Apr 18;486(7403):346-52</RefSource>                <PMID Version="1">22522925</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncogenesis. 2017 Aug 7;6(8):e369</RefSource>                <PMID Version="1">28785073</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nature. 2012 Oct 4;490(7418):61-70</RefSource>                <PMID Version="1">23000897</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Fly (Austin). 2012 Apr-Jun;6(2):80-92</RefSource>                <PMID Version="1">22728672</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Natl Cancer Inst. 2015 Apr 13;107(7):null</RefSource>                <PMID Version="1">25868578</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Source Code Biol Med. 2016 Dec 15;11:13</RefSource>                <PMID Version="1">27999612</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Med. 2016 Jan;22(1):97-104</RefSource>                <PMID Version="1">26657142</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nature. 2016 May 02;534(7605):47-54</RefSource>                <PMID Version="1">27135926</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2013 Nov 1;31(31):3997-4013</RefSource>                <PMID Version="1">24101045</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Med. 2015 Oct 15;13:266</RefSource>                <PMID Version="1">26467651</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10869-74</RefSource>                <PMID Version="1">11553815</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Cell. 2017 Aug 14;32(2):169-184.e7</RefSource>                <PMID Version="1">28810143</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2010 Jun 1;28(16):2784-95</RefSource>                <PMID Version="1">20404251</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Carcinogenesis. 2009 Oct;30(10):1696-701</RefSource>                <PMID Version="1">19651820</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Biotechnol. 2013 Mar;31(3):213-9</RefSource>                <PMID Version="1">23396013</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <CoiStatement>Y.S.Y. provided consultancy and received honoraria from Novartis; A.P.S. and D.Y.C. are employees of Novartis; R.A.D. has received honoraria from Novartis; and S.B.K. has received research support from Novartis. All remaining authors have declared no competing interests.</CoiStatement>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2017</Year>                <Month>10</Month>                <Day>19</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="revised">                <Year>2018</Year>                <Month>05</Month>                <Day>28</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>06</Month>                <Day>05</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>8</Month>                <Day>1</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>8</Month>                <Day>1</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>8</Month>                <Day>1</Day>                <Hour>6</Hour>                <Minute>1</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>epublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30062102</ArticleId>            <ArticleId IdType="doi">10.1038/s41523-018-0070-x</ArticleId>            <ArticleId IdType="pii">70</ArticleId>            <ArticleId IdType="pmc">PMC6062514</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>